# Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer

> **NCT07441369** · PHASE2 · ENROLLING_BY_INVITATION · sponsor: **Fudan University** · enrollment: 16 (estimated)

## Conditions studied

- Liver Metastases From Colorectal Cancer (mCRC)

## Interventions

- **DRUG:** Abemaciclib
- **DRUG:** Oxaliplatin
- **DRUG:** Calcium Folinate
- **DRUG:** 5-Fluorouracil
- **DRUG:** Irinotecan

## Key facts

- **NCT ID:** NCT07441369
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-05-01
- **Primary completion:** 2027-04-30
- **Final completion:** 2027-04-30
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2026-04-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07441369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07441369, "Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07441369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*